The 20 Best Non-Muscle Invasive Bladder Cancer Doctors Near Me in Newark, NJ

Nicholas Karanikolas is an Oncologist and a Urologist practicing medicine in Staten Island, New York. Dr. Karanikolas is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Ureteroscopy, and Prostatectomy. Dr. Karanikolas is board certified in American Board Of Urology.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Michael Ciccone is a Urologist practicing medicine in Belleville, New Jersey. Dr. Ciccone is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Urethral Stricture, Enlarged Prostate (BPH), Urinary Incontinence, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Ciccone is board certified in American Board Of Urology.

Girish Kulkarni is a Urologist practicing medicine in New York, New York. Dr. Kulkarni is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Prostatectomy.

Eugene Pietzak is a Urologist practicing medicine in New York, New York. Dr. Pietzak is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Vasectomy. Dr. Pietzak is currently accepting new patients.

Alexandre Zlotta practices practicing medicine in Canada. Mr. Zlotta is rated as an Elite expert by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Prostatectomy.

John Sfakianos is a Urologist practicing medicine in Astoria, New York. Dr. Sfakianos is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Sfakianos is currently accepting new patients.

Andrew Burachinsky is a Cardiologist practicing medicine in Belleville,, New Jersey. Dr. Burachinsky is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His clinical expertise encompasses Atherosclerosis, Angina, Coronary Heart Disease, and Glucocorticoid-Remediable Aldosteronism.

Michael Benson is a Urologist practicing medicine in Belleville, New Jersey. Dr. Benson is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Paraphimosis, UPJ Obstruction, Hydronephrosis, Ureteroscopy, and Vasectomy. Dr. Benson is board certified in American Board Of Urology.

Khalil Kaid is a Cardiologist practicing medicine in Maplewood,, New Jersey. Dr. Kaid is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Thrombophlebitis, Angina, Hypertension, Angioplasty, and Atherectomy.

Kenneth Ring is a Pediatrics specialist and a Urologist practicing medicine in Roselle, New Jersey. Dr. Ring is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Acute Cystitis, and Ureteroscopy. Dr. Ring is board certified in American Board Of Urology. Dr. Ring is currently accepting new patients.

Jay Basillote is a Urologist practicing medicine in Staten Island, New York. Dr. Basillote is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Carbuncle, Perirenal Abscess, Boils, Ureteroscopy, and Prostatectomy.

Dr. Das grew up in Brooklyn and then Long Island.Dr. Das served on active duty as a Major and Chief of Urology at USAF Hospital Kirtland in Albuquerque NM. He then established a busy research and clinical program in neuro-urology, incontinence, BPH, and voiding dysfunction at AMC Hospital and Albany Medical College, where he was an Associate Professor of Surgery/Urology. He then moved to become Director of the Center for Neuro-urology and Continence at Beth Israel Deaconess Medical Center and Harvard Medical School. After 18 years in Boston, he took his current position as Chief of Urology at SIUH.Urologic expertise includes Neuro-urology (urologic problems due to neurologic disease such as MS, Parkinson s disease etc), BPH (prostate enlargement), male and female incontinence, urethral strictures and complex urodynamics. Also seen are kidney and bladder stones, bladder tumors, elevated PSA and general urologic problems including hematuria ( blood in urine), family planning, recurrent urinary tract infections etc.Awards and Recognition:James C. Kimbrough Memorial Award for Urologic ResearchMontague L. Boyd Essay Contest- First PrizeThe Air Force Commendation MedalBoston Magazine Top Doctors 2008-2015, 2017-2021Castle-Connolly Best Doctors in America 2008-2021Panel Member: National AUA guideline on the diagnosis and treatment of non-neurogenic overactive bladderPanel member: National AUA Guideline on Management of Benign prostatic hyperplasia/ lower urinary tract symptomsDr. Das has published over 50 scientific articles and book chapters and given presentations at numerous national and international urology meetings primarily on topics related to BPH, incontinence, voiding dysfunction, and sacral neuro-modulation. He has performed numerous clinical trials in these areas. Selected publications are listed below.Abello A, Badin J, Das AK. Worsening disability status in multiple sclerosis predicts urologic complications. Int Urol Nephrol. 2020 Jan 25.Abello A, Dewolf WC, Das AK. Expectant long-term follow-up of patients with chronic urinary retention. Neurourol Urodyn. 2019 Jan;38(1):305-309Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE, Scarpero HM, Tessier CD, and Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 188 (6s) 2455-2463, 2012Das AK, Carlson A, Hull M, and the US MDT-103 study group. Improvement in depression and quality of life following sacral nerve stimulation for the treatment of voiding dysfunction. Urology. 2004 Jul;64(1): 62-68.Patient education booklet: Living better with BPH. Anurag K. Das-medical editor. Harvard Medical School, Harvard Health Publications. Dr. Das is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Neurogenic Bladder, Enlarged Prostate (BPH), Urinary Incontinence, Prostatectomy, and Aquablation. Dr. Das is board certified in American Board Of Urology.

Adley Raboy is a Urologist practicing medicine in Staten Island, New York. Dr. Raboy is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Testicle Lump, Scrotal Masses, Ureteroscopy, and Prostatectomy.

John Gianis is a Urologist practicing medicine in Summit, New Jersey. Dr. Gianis is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Enlarged Prostate (BPH), Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. Dr. Gianis is board certified in American Board Of Urology. Dr. Gianis is currently accepting new patients.

Dr. Naeem Rahman is the medical director for Atlantic Medical Group Urology in Union and Somerset Counties. A board-certified urologist, he specializes in the treatment of urological cancers, with a focus on prostate and bladder cancer, as well as diseases and disorders of the urinary tract in both men and women. With nearly 20 years of professional experience, Dr. Rahman is known for his expertise in nerve-sparing surgery, robotic surgery, open surgery, and advanced focal therapies like cryotherapy and ablation for salvage prostate cancer. He is committed to restoring normal function and improving the quality of life for his patients, offering a comprehensive, multidisciplinary approach to prostate cancer treatment, including active surveillance and a focus on men’s sexual health.Dr. Rahman delivers concierge-level care, providing both surgical and clinical excellence while maintaining a warm, compassionate approach. He served as chief of Urology and director of Robotic Surgery at Vassar Brothers Medical Center in Poughkeepsie, NY, overseeing nearly 1,000 robotic and laparoscopic procedures. In addition, he directed an advanced prostate cancer clinic, providing the latest treatment options for patients with disease progression. His practice offers a robust male sexual health medicine program, with specialized care for erectile dysfunction (ED).Dedicated to advancing state-of-the-art therapeutics, Dr. Rahman has served as a primary investigator on several clinical trials for bladder and prostate cancer. He is a member of the American Urological Association and the Society of Robotic Surgery. After earning his degree from Wake Forest University School of Medicine, Winston-Salem, NC, Dr. Rahman completed residency programs in surgery and urology at Eastern Virginia Medical School in Norfolk, VA. He is an assistant clinical professor at New York Medical College, Valhalla, NY. Dr. Rahman is also a participating provider of the Atlantic Accountable Care Organization. Dr. Rahman is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Bilateral Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Rahman is board certified in American Board Of Urology. Dr. Rahman is currently accepting new patients.

Thomas Bradley, MD, FACP, is Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As System Head for Genitourinary Cancers for the Northwell Health Cancer Institute, Dr. Bradley has special expertise in the management of prostate, kidney, bladder, and testicular cancers. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Bradley maintains an active practice where he focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. Dr. Bradley has a keen interest in the education of future physicians as evidenced by his directorship of the Fellowship program in Hematology and Medical Oncology for many years. His research work as principal investigator for numerous drug trials and multiple collaborations has resulted in dozens of publications and abstracts. Dr. Bradley earned his medical degree from the University of Monterrey School of Medicine. He trained in internal medicine as well as hematology and medical oncology at the State University of New York at Downstate Medical Center. Dr. Bradley is an active member of the American Society of Hematology, American Society of Clinical Oncology, American Association for Cancer Research and the American College of Physicians. Dr. Bradley is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, and Bone Marrow Aspiration. Dr. Bradley is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Richstone is board certified in American Board Of Urology.

Margarette Bryan is a Hematologist and an Oncologist practicing medicine in Newark, New Jersey. Dr. Bryan is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Philadelphia-Negative Chronic Myeloid Leukemia.

Piotr Kisza is an Interventional Radiologist practicing medicine in East Orange, New Jersey. Dr. Kisza is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Ascites, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Liver Embolization, and Endoscopy.